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ABSTRACT
The aim of this study was to isolate cis-acting
regulatory elements for the generation of transgenic
zebrafish models of neurodegeneration. Zebrafish
enolase-2 (eno2) showed neuronal expression
increasing from 24 to 72h post-fertilization (hpf)
and persisting through adulthood. A 12kb eno2
genomic fragment, extending from 8kb upstream of
exon 1 to exon 2, encompassing intron 1, was
sufficient to drive neuronal reporter gene expres-
sion in vivo over a similar time course. Five
independent lines of stable Tg(eno2:GFP) zebrafish
expressed GFP widely in neurons, including popula-
tions with relevance to neurodegeneration, such as
cholinergic neurons, dopaminergic neurons and
cerebellar Purkinje cells. We replaced the exon
2-GFP fusion gene with a cDNA encoding the
4-repeat isoform of the human microtubule-
associated protein Tau. The first intron of eno2
was spliced with high fidelity and efficiency from the
chimeric eno2-Tau transcript. Tau was expressed at
»8-fold higher levels in Tg(eno2:Tau) zebrafish
brain than normal human brain, and localized to
axons, neuropil and ectopic neuronal somatic
accumulations resembling neurofibrillary tangles.
The 12kb eno2 promoter drives high-level transgene
expression in differentiated neurons throughout the
CNS of stable transgenic zebrafish. This regulatory
element will be useful for the construction of
transgenic zebrafish models of neurodegeneration.
INTRODUCTION
The zebraﬁsh has shown great utility as a model organism
for studying the molecular mechanisms of vertebrate
development. The rapid external development and
transparency of zebraﬁsh embryos allowdirect observation
of developmental processes and the deployment of
ﬂuorescent reporter genes to facilitate examination of
spatial and temporal gene expression patterns in living
embryos (1,2). The availability of eﬃcient techniques
for manipulation of gene expression enables studies of
gene function to be executed readily (3). The ease with
whichgeneticandsmallmolecule screenscanbecarriedout
has allowed the identiﬁcation of novel genetic pathways
involved in speciﬁc developmental processes and the
isolation of novel chemical modiﬁers (4–7). More recently,
it has been suggested that many of these advantages might
apply to the study of human diseases: valuable insights
into disease pathogenesis, or leads to new therapeutic
approaches, could be provided by high-content small
molecule screens, genetic suppressor screens, observation
of disease progression in real time in vivo, using ﬂuorescent
reporters to label cell populations of interest, and rapid
hypothesis-testing experiments in statistically robust
samples of larvae (8–10). Exploitation of these techniques
could provide powerful means to analyse human
disease. However, full realization of this potential will
be critically dependent on the development of zebraﬁsh
models that faithfully recapitulate relevant pathological
mechanisms.The long-term objectives of our work are to
elucidate mechanisms of neurodegeneration and to identify
novel neuroprotective compounds to treat patients with
neurodegenerative diseases. We aim to accomplish these
objectives by exploiting the advantageous features of the
zebraﬁsh as a model. The zebraﬁsh is an appropriate
organism in which to study neurodegeneration. As a
vertebrate, the basic organization and divisions of the
nervous system are similar to those of other vertebrates,
including humans (11). The zebraﬁsh CNS contains
specialized neuronal populations of direct relevance to
human neurodegenerative diseases, for example, dopami-
nergic neurons (12), cerebellar Purkinje cells (13) and
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CNS contains oligodendrocytes (15) and astrocytes (16),
the human homologues of which may play central roles in
neurodegeneration through critical neural–glial interac-
tions. Finally, there is extensive genetic and biochemical
similarity between the zebraﬁsh and human. Many genes
involved in human neurodegenerative diseases have highly
conserved orthologues in the zebraﬁsh (17–19). Zebraﬁsh
neurons are susceptible to toxins that target pathways
implicated in sporadic neurodegenerative diseases (20–23).
These considerations suggest that it may be possible to
recapitulate neurodegeneration in the zebraﬁsh brain
through similar biochemical mechanisms to those under-
lying human disease. Consequently, generation of repre-
sentative disease models may be feasible, enabling the
analyses described above to yield insights into pathogenic
mechanisms and identiﬁcation of therapeutic targets.
As a ﬁrst step towards developing zebraﬁsh models of
neurodegenerative disease, we would like to test the
hypothesis that zebraﬁsh, engineered to express genes
associated with neurodegeneration in humans, will
develop histological and biochemical abnormalities
reﬂecting those found in the relevant diseases. This
hypothesis can be tested by generating transgenic zebraﬁsh
expressing appropriate genes in CNS neurons, and then
carrying out analysis for evidence of neuronal cell death or
dysfunction, and histopathological features or biochem-
ical abnormalities reminiscent of the human diseases.
Generation of transgenic models relies on the availability
of cis-acting regulatory elements that drive transgene
expression in an appropriate spatial and temporal pattern.
For a neurodegenerative disease model, the regulatory
elements should have the following properties: (i) expres-
sion in a wide variety of neurons, in order to study the
diﬀerential vulnerability of speciﬁc neuronal subpopu-
lations, which is a key feature of human diseases;
(ii) expression commencing in diﬀerentiated neurons
after the earliest stages of development, since a pathogenic
transgene might provoke pathological changes in neuronal
precursors through disruption of developmental mechan-
isms that are not relevant to late-onset neurodegeneration;
(iii) expression persisting into adulthood, in order to
examine the eﬀects of aging on pathogenesis and disease
progression; (iv) expression that is suﬃciently robust to
provoke a phenotype. The purpose of the present study
was to isolate suitable cis-acting regulatory elements with
these properties.
Mammals have three forms of the glycolytic enzyme
enolase, each encoded by a separate gene. The mammalian
ENO2 gene encodes the neuron-speciﬁc g-enolase iso-
enzyme (24), which is expressed in mature neurons
throughout the neuraxis; consequently, neuron-speciﬁc
enolase (NSE) is frequently used as a marker to identify
cells with neuronal diﬀerentiation in human histopathol-
ogy samples (24). A 1.8kb fragment of the rat ENO2
promoter drives transgene expression widely in mature
neurons of the mouse CNS (25) and has been used
to generate transgenic rodent models for the study
of neurodegeneration (26–31). Since endogenous zebraﬁsh
promoters have been associated with high transgenesis
rates and reproducible expression patterns (32),
we decided to clone the zebraﬁsh orthologue of ENO2
and to isolate its promoter as a resource for generating
transgenic models of neurodegeneration in zebraﬁsh.
In this study, we identiﬁed and characterized the
zebraﬁsh eno2 gene. Zebraﬁsh eno2 is ﬁrst expressed in
the developing nervous system at 24hpf; however, steady-
state levels of the transcript become signiﬁcantly more
abundant later during development and robust expression
persists through adulthood. We isolated the zebraﬁsh eno2
promoter region, and showed that its activity in driving
GFP reporter gene expression in vivo was enhanced
by the presence of the ﬁrst intron, which contains a
putative CpG island. Five independent lines of
Tg(eno2:GFP) zebraﬁsh, in which green ﬂuorescent
protein was expressed under the transcriptional control
of a 12kb zebraﬁsh eno2 promoter fragment, showed
widespread neuronal GFP expression, including choliner-
gic, dopaminergic GABAergic and cerebellar Purkinje
neurons. In order to assess the utility of this promoter
element for constructing disease models, we replaced GFP
with a cDNA expressing the 4-repeat isoform of the
human microtubule-associated protein Tau. Stable trans-
genic Tg(eno2:Tau) zebraﬁsh showed widespread CNS
neuronal expression of Tau, at high levels compared with
normal human brain. Human 4R-Tau was found within
axons, neuropil and in ectopic accumulations in neuronal
cell bodies of Tg(eno2:Tau) zebraﬁsh. These data show
that cis-acting elements from the zebraﬁsh eno2 regulatory
region will be useful for stable expression of transgenes in
neurons throughout the zebraﬁsh CNS. The eno2 promo-
ter will enable us to test the hypothesis that biochemical
and histological changes representative of human diseases
may be provoked in susceptible neuronal populations
by expression of mutant transgenes.
MATERIALS AND METHODS
Zebrafish andmicroscopy
Experiments were carried out in accordance with
Institutional Animal Use and Care Committee regulations
and approvals. Adult stocks of strain AB
  zebraﬁsh were
maintained at 28.58C and euthanized by deep tricaine
anaesthesia followed by exposure to ice-cold water.
Embryos were raised in E3 buﬀer (5mM NaCl, 0.17mM
KCl, 0.33mM CaCl2, 0.33mM MgSO4). Microscopy was
carried out after tricaine anaesthesia to prevent move-
ment. Images of free-ﬂoating whole larvae were obtained
using an inverted microscope, and confocal images were
obtained after embedding anaesthetized larvae in 3% low
melting point agarose in E3 buﬀer.
Northern blot
RNA was separated on a 1.2% agarose formaldehyde/
MOPS gel and transferred to Nytran-N membrane
(Schleicher & Schuell BioScience, Keene, NH). eno2
antisense cRNA probe was generated by in vitro
transcription of a plasmid template containing 307bp
of the eno2 open reading frame and 50UTR using
digoxigenin-conjugated UTP to label the antisense
cRNA probe (Roche, Indianapolis, IN, USA).
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Austin, TX< USA) supplemented with Torula RNA
(1mg/ml ﬁnal concentration; Sigma, St Louis, MO, USA),
followed by addition of cRNA probe (20ng/ml ﬁnal
concentration) to the hybridization buﬀer. Blots were
washed in 2  SSC, 0.1% SDS and 0.1  SSC, 0.1%, SDS.
Probe was detected with alkaline-phosphatase (AP)
conjugated anti-DIG FAb (Roche, Indianapolis, IN,
USA), in maleic acid buﬀer, 1% blocking substrate, and
revealed by exposure to photographic ﬁlm after incuba-
tion with a light-emitting AP substrate (CDP-star, Roche,
Indianapolis, IN, USA).
Whole mount mRNA insitu hybridization
Embryos were raised in E3 buﬀer, 0.003% 1-phenyl-2-
thiourea to prevent pigment formation, ﬁxed overnight at
48C in 4% paraformaldehyde (PFA) in phosphate-
buﬀered saline pH 7.5 (PBS), washed in PBS, dehydrated
in methanol and stored at –208C. Prior to hybridization,
embryos were treated with acetone at –208C, re-hydrated
in 50 and 30% methanol and then diethylpyrocarbonate
(DEPC)-treated PBS, followed by protease-K (10mg/ml)
at room temperature for 5–30min, followed by post-ﬁxing
in 4% PFA and washing in PBTw (PBS, 0.1% Tween-20,
0.2% bovine serum albumin). Pre-hybridization was
carried in 50% formamide, 2  SSC, 0.3% 3-[(3-cholami-
dopropyl)dimethylammonio]-1-propanesulphonate
(CHAPS), 1mg/ml torula RNA, 50mg/ml heparin,
followed by the addition of 150ng/ml cRNA probe.
Embryos were washed in 50% formamide, 2  SSC, 0.3%
CHAPS, then 2  SSC, 0.3% CHAPS, followed by 0.2 
SSC, 0.3% CHAPS. Probe was detected using AP
conjugated anti-DIG antibody diluted in maleic acid
buﬀer, and revealed by incubation in BM Purple (Roche,
Indianapolis, IN).
mRNA insitu hybridization in brain sections
Zebraﬁsh brains were ﬁxed in 4% PFA at 48C for 6h,
washed with PBS and cryoprotected in PBS-sucrose. Ten
micrometer thick cryosections on SuperFrost slides
(Fisher, Pittsburgh, PA), were post-ﬁxed in 4% PFA,
carbethoxylated with 0.1% DEPC in PBS (33), washed
in 5  SSC, and post-ﬁxed in 4% PFA. Following
incubation in hybridization buﬀer (UltraHyb, Ambion,
Austin, TX) supplemented with Torula RNA (4mg/ml
ﬁnal concentration; Sigma, St Louis, MO) for 1h at 688C,
DIG-labelled RNA probe (ﬁnal concentration 0.2ng/ml)
was added to the buﬀer and sections were incubated in
a humid chamber overnight at 688C, following which
they were washed in 2  SSC, 1  SSC then 0.1  SSC.
Probe was detected using an AP-conjugated anti-DIG
FAb diluted 1:1000 in maleic acid buﬀer, 1% blocking
substrate (Roche), and revealed by incubation in
a colorigenic AP substrate (BM-Purple, Roche,
Indianapolis, IN, USA).
RT–PCR, 5’RACE and3’RACE
For RT–PCR, total RNA from whole adult zebraﬁsh
brains was subjected to reverse transcription using
SuperScript III (Invitrogen, Carlsbad, CA, USA).
PCR ampliﬁcation was carried out using primers com-
plementary to eno2 exon1F: 50-CGC TCT GTT TTC
CTC TCT CTT CCG-30 and Tau R: 50-AAT CCT GGT
GGC GTT GGC CT-30; beta actin F: 50- ATG GAT GAG
GAA ATC GCT GC-30 and R: 50- AGC CTC AGT GAG
CAC GAC AG-30; eno2 F: 50-ATG TCT GTT GTA AGC
ATC AT -30 and R: 50-GAT GTG TCT GTC TGC ATT
TG -30.5 0 and 30 RACE were carried out as described (17),
using zebraﬁsh eno2 primers 30RACE: 50-ATC TGA GCG
TCT CGC CAA AT-30, and 50RACE: 50-ATG ATG GCT
GGC CCG AGA GTG T-30. Products were cloned in
pGEM-T (Promega, Madison, WI, USA) and sequenced.
Multiple sequences were aligned and compared using
AlignX.
DNA constructs
An EcoRI/AﬂII restriction fragment containing eGFP-
poly(A) was obtained by digestion of pEGFP-1 (Clontech,
Mountain View, CA, USA), and ligated into the
EcoRI/PmeI sites of pBluescript SK-I-Sce1 (a kind gift
from Dr Michael Tsang, University of Pittsburgh) to
make pBS-I-Sce1-GFP. Homologous zebraﬁsh eno2 arms
were ampliﬁed from BAC zC51M24 (CHORI21 library)
by PCR using primers 50-GGA ATT CCA TCA CAA
TGT ATC AGC-30 and 50-GTA CCC ATG GCA ATG
ATG CTT ACA AC-30 (30arm; eno2 exon 2) and 50-GGG
GTA CCT GTT AGT AAA GGC AGA T-30 and 50-A
ATT CAA TGG CAC GTT TGA TCG-30 (50arm; eno2 50
genomic ﬂanking sequence). The homologous arms were
inserted into the EcoRI/NcoI sites (30 arm) or KpnI/
EcoRI sites (50 arm) of pBS-I-Sce1-GFP, such that the
eGFP ORF was in frame with exon 2 from the zebraﬁsh
eno2 gene. The resulting plasmid was veriﬁed by restric-
tion digest and direct DNA sequencing, and then
linearized by EcoRI digest. A 12kb fragment of the eno2
gene was captured from BAC zC51M24 using gap repair
recombination (the inducible bacterial strains for carrying
out the recombination were a kind gift from Dr Neal
Copeland, NCI). DY380 cells were transformed with BAC
zC51M24 by electroporation. DY380-BACzC51M24 cells
were grown at 328Ct oO D 590=0.5 then induced at 428C
for 15min before being transformed with linearized
plasmid by electroporation. Recombinants were identiﬁed
by ampicillin resistance, and veriﬁed by restriction digest
and direct DNA sequencing. A similar strategy was used
for cloning the eno2:4R-Tau gene cassette, except that the
Tau ATG replaced the zebraﬁsh eno2 ATG in order to
preserve the N-terminus of the resulting protein. The
homologous arms were generated by PCR ampliﬁcation
from BAC zC51M24, using the following primers:
50-GGG GTA CCT GTT AGT AAA GGC AGA TTC-30
and 50-CCG CTC GAG TCC ACA TTA CCT TCT
GTT G-30 (50 arm; eno2 50genomic ﬂanking sequence), and
50-CCG CTC GAG TCC ATC ACA ATG TAT CAG C-30
and 50-CTC ACC ATG GCA ATG ATG CTT ACA ACA
GAA GGC CTT AAA GAC AAG-30 (eno2 intron 1),
and cloned into the XhoI/NcoI sites (50 arm) or KpnI/
XhoI sites of pBS-I-Sce1-GFP. The open reading frame of
human 4-repeat Tau was ampliﬁed from plasmid t2
(a kind gift from Dr Matthew Farrer, Mayo Clinic,
Nucleic Acids Research, 2007, Vol. 35, No. 19 6503Jacksonville, Florida) by PCR using primers 50-ATG GCT
GAA CCC CGA CAG GAG-30 and 50-GAC CCA TGG
ATC CTC ACA AAC CCT GCT TGG C-30, and cloned
into the StuI/NcoI sites of pBS-I-Sce1-eno2-GFP. The
IRES sequence derived from pIRES2-eGFP (Clontech)
was inserted into the BamHI/NcoI sites of pBS-I-Sce1-
eno2:Tau-GFP. The resulting plasmid was linearized
using XhoI prior to transformation and recombination,
as described above.
Transgenic zebrafish
A restriction digest containing the following components
was prepared on ice: plasmid DNA (pBS-I-Sce1-
eno2:GFP, or pBS-I-Sce1-eno2:Tau-IRES-GFP) 0.6mg,
injection dye (0.5% phenol red, 240mM KCl, 40mM
HEPES pH 7.4) 1ml, 10  I-Sce1 buﬀer (100mM Tris–
HCl, 100mM MgCl2, 10mM Dithiothreitol, pH 8.8)
0.5ml, I-Sce1 (New England Biolabs) 1ml (5U), ddH2O
to total 10ml. Single cell embryos were microinjected with
0.5nl of the restriction digest reaction, containing 30pg
DNA, using a glass micropipette. All surviving ﬁsh were
raised to sexual maturity and crossed in pairs to identify
germline chimeras. The genotype of progeny embryos of
F0 pBS-I-Sce1-eno2:GFP and pBS-I-Sce1-eno2:Tau-
IRES-GFP microinjected ﬁsh was determined by PCR
of pooled embryo lysate genomic DNA using primers
50-CGT AAA CGG CCA CAA GTT CAG C-30 and
50-CGA TGT TGT GGC GGA TCT TGA AG-30. Pairs
of ﬁsh that transmitted the transgene to progeny
embryos were then outcrossed to wild-type ﬁsh and
embryo genotyping repeated, in order to determine which
one of each pair was the germline chimera. F1 progeny
of each germline F0 ﬁsh were then raised to adulthood.
Tg(eno2:GFP) F1 ﬁsh were identiﬁed by epiﬂuorescence
microscopy of F2 embryos after outcross to wild-type
ﬁsh. Tg(eno2:4R-Tau) ﬁsh were identiﬁed by PCR of
genomic DNA extracted from tail ﬁn. Two- to three-
month-old ﬁsh were anaesthetized in 4% tricaine (Acros).
A small segment of caudal ﬁn was excised and incubated
in 100ml of DNA extraction buﬀer [10mM Tris pH 8.0,
10mM EDTA, 200mM NaCl, 0.5% SDS and 200ug/ml
proteinase K (Invitrogen)] at 558C for 3h. The sample
was then heated to 1008C for 5min to inactivate
proteinase K, and 0.6ml of each sample was used as a
template for PCR using the GFP primers shown above.
Each line of transgenic ﬁsh was derived from a single F1
founder, and each F1 founder was derived from a single
F0 germline chimera. Stocks were maintained by
genotyping as above. The data reported here are derived
from F2, F3 and F4 generation zebraﬁsh.
Immunohistochemistry (IHC) and immunofluorescence
Adult ﬁsh brains were dissected and ﬁxed in 4% PFA,
followed by cryoprotection in PBS-sucrose. Cryosections
measuring 20mm were incubated overnight at 48C with
primary antibody, diluted: 1:500 (GFP; cat# MAB3580
Chemicon, Temecula, CA, USA), 1:250 (ChAT; cat#
AB144P, Chemicon; this antibody was incubated with
sections for 72h at 48C), 1:100 (IP3R1; cat#ACC-019,
Alomone Labs, Jerusalem, Israel), 1:1000 (GABA;
cat# A2052, Sigma), 1:500 (Human Tau; cat#AHB0042,
Biosource, Camarillo, CA, USA) or 1:500 (TH; cat#
AB152, Chemicon), in carrier buﬀer (PBS, 1% goat or
donkey serum, 1% BSA). For IHC, a biotinylated anti-
mouse secondary antibody (2mg/ml; cat# BA-2000, Vector
Laboratories, Burlingame, CA, USA) was diluted 1:200 in
carrier buﬀer, followed by staining in NovaRed (Vector
Laboratories) and counterstaining in Mayer’s haemato-
xylin (Sigma, St Louis, MO, USA). For immunoﬂuores-
cence, primary antibodies were detected using Alexa-488
(anti mouse) and Alexa-555 (anti-rabbit or goat) con-
jugated secondary antibodies (Invitrogen, Carlsbad, CA,
USA), diluted 1:2000 in carrier buﬀer.
Western blot
Whole brains from 3-month-old zebraﬁsh were sonicated
in RIPA lysis buﬀer (50mM Tris, pH 8.0, 150mM NaCl,
1% NP-40, 5mM EDTA, 0.5% sodium deoxycholate and
0.1% SDS), in the presence of protease inhibitors
(complete mini, Roche, Indianapolis, IN, USA) on ice.
The homogenate was centrifuged at 20000g for 20min at
48C. The protein concentration of each brain extract was
determined by Bradford assay and 10mg was loaded onto
12% SDS-PAGE after boiling in SDS sample buﬀer, and
electroblotted onto PVDF membrane (Bio-Rad). The
membrane was blocked in 150mM NaCl, 100mM
Tris–HCl pH 7.5, 0.1% Tween-20 (TBST), 10% dried
non-fat milk for 60min at room temperature, probed with
mouse monoclonal anti-Tau antibody (1:500,
cat#AHB0042, Biosource, Camarillo, CA, USA) or
polyclonal anti-actin antibody (1:1000; cat#A2066,
Sigma, St Louis, MO, USA) overnight at 48C in TBST,
10% milk, washed in TBST, and bound antibody detected
using an HRP conjugated secondary antibody (goat anti-
mouse, cat# 31430, Pierce, Rockford, IL; goat anti-rabbit,
cat# 4010-05, Southern Biotech, Birmingham, AL) diluted
1:10,000 in TBST and chemiluminescent substrate
(ECL, Amersham Biosciences, Chalfont, UK).
RESULTS
Identification andexpression patternof zebrafish eno2
A TBLASTN search of the zebraﬁsh genome, using the
amino acid sequence of human g-enolase as a probe,
identiﬁed four gene loci encoding proteins with homology
to g-enolase, located on zebraﬁsh chromosomes 2, 19, 22
and 23. Further database searches identiﬁed ESTs and
mRNAs corresponding to each of these four genes, but no
additional zebraﬁsh enolase sequences were found. The
protein sequences predicted by the four zebraﬁsh genes
were aligned with the primary sequences of human, rat
and mouse a-, b- and g-enolases and evolutionary
relationships between the proteins were inferred by
construction of a dendrogram using the neighbour joining
method of Saitou and Nei (34). The enolase encoded by
the zebraﬁsh chromosome 19 gene locus was most closely
related to human and rodent g-enolases (Figure 1A).
We refer to this zebraﬁsh gene as eno2 and its product as
g-enolase. Human and zebraﬁsh g-enolases showed 84%
identity and 92% similarity (Figure 1B). The enolase
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closely related to mammalian b-enolases, suggesting that
this gene should be designated zebraﬁsh eno3. The
enolases encoded by the zebraﬁsh chromosome 22 and
chromosome 23 gene loci were highly homologous to one
another, and to mammalian a-enolases, suggesting that
there are two zebraﬁsh eno1 genes.
We cloned the zebraﬁsh eno2 transcript from adult
brain by RT–PCR (data not shown), conﬁrming the
sequence of the transcript and predicted protein, and
enabling generation of cRNA probes for expression
pattern studies. Hybridization of an eno2 antisense
cRNA probe with a northern blot containing total RNA
from adult zebraﬁsh brain, muscle and gut revealed a
single brain-speciﬁc eno2 mRNA of 3.5kb (Figure 2A).
RNA in situ hybridization was used to localize expression
of the eno2 transcript within the adult brain (Figure 2B).
The eno2 antisense cRNA probe hybridized with cells that
showed neuronal morphology (Figure 2B, inset panel) and
were located in grey matter nuclei and laminae throughout
the brain and spinal cord (Figure 2B, upper two panels).
The most prominent labelling was seen in the telencepha-
lon, deep laminae of the optic tectum, cranial nerve motor
nuclei, granule cell and Purkinje cell layers of the
cerebellum and brainstem reticular formation. Under
identical conditions, a sense control eno2 cRNA probe
did not label sections (Figure 2B lower panel), and a probe
for the oligodendrocyte marker mpz showed a non-
overlapping hybridization pattern with eno2. Cells expres-
sing mpz were identiﬁed as oligodendrocytes by their
smaller size compared with neuronal cells expressing
eno2, and by their location in the optic tracts, medial
longitudinal fasciculus and white matter laminae of the
tectum (Figure 2C). These controls conﬁrm the speciﬁcity
of the eno2 expression pattern demonstrated by this
technique, and show that the widespread hybridization
pattern of the eno2 cRNA probe to brain sections is
attributable to pan-neuronal expression of eno2 rather
than non-speciﬁc probe hybridization. Northern blot
analysis of total RNA samples from whole embryo lysates
showed that the 3.5kb eno2 transcript was ﬁrst detected at
48h post-fertilization (hpf), but its expression level
increased markedly between 48 and 72hpf to reach a
maximum at 72hpf; expression continued at a similar
level thereafter (Figure 2D). Weak eno2 expression was
ﬁrst detected by whole mount RNA in situ hybridization
in the developing nervous system at 24hpf (Figure 2E).
In agreement with the northern blot analysis, the
expression level increased thereafter, such that abundant
eno2 mRNA was readily detected at 72hpf. Expression
was restricted to the nervous system and was most
prominent within the brain, spinal cord and retina
(Figure 2E). Under identical conditions, no signal was
seen when embryos were hybridized with an eno2 sense
control probe (Figure 2E).
Zebrafish eno2 transcription startsite and genomic
organization
The expression pattern of zebraﬁsh eno2 reproduced many
of the features that we sought to emulate in a transgenic
neurodegeneration model. Consequently, we proceeded to
characterize the gene and isolate its cis-acting regulatory
elements.
We employed 50rapid ampliﬁcation of cDNA ends
(RACE), using the tobacco acid pyrophosphatase (TAP)
method (17), in order to locate the eno2 transcriptional
start site and promoter (Figure 3A). Ampliﬁcation of
cDNA derived from TAP-treated (TAP
+), adapter ligated
RNA, using a RACE adapter primer and a gene-speciﬁc
primer, yielded several products of 300–320bp. Under the
same conditions, no products were generated by ampliﬁ-
cation of cDNA derived from an identical RNA sample
which was not subjected to TAP treatment (TAP
 ) before
adapter ligation. Using two eno2 gene-speciﬁc primers,
instead of the RACE primer, ampliﬁcation products were
generated from both TAP
+ and TAP
  samples. These
controls show that the RNA samples and reverse
transcription were equivalent between the TAP
+ and
TAP
  samples; however, adapter ligation and RACE
ampliﬁcation was dependent on cleavage of the mRNA
cap structure by TAP. Consequently, the boundary
between the RACE adapter and the eno2 sequence in the
Figure 1. The zebraﬁsh eno2 orthologue. (A) Four zebraﬁsh enolase genes identiﬁed by BLAST search were located on chromosomes 2, 19, 22 and
23. The predicted amino acid sequences encoded by each of these genes were aligned with the human, rat and mouse a-, b- and g-enolase sequences
using the AlignX implementation of the ClustalW algorithm. The dendrogram shown was generated using the neighbour joining method of Saitou
and Nei (34). The inferred evolutionary relationships between the zebraﬁsh genes and their mammalian orthologues suggest that zebraﬁsh g-enolase
is encoded by the chromosome 19 gene locus, to which we refer as ‘eno2’ throughout the remainder of the article. (B) An alignment of zebraﬁsh
g-enolase with human g-enolase is shown. Non-similar amino acid substitutions are shaded black and conservative substitutions are shaded grey.
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50 boundary of the eno2 transcript and therefore the
transcriptional start site of the eno2 gene. We cloned
the RACE products and sequenced 16 randomly chosen
clones. Sequence analysis disclosed the presence of an
untranslated ﬁrst exon in the eno2 gene, which is located
3.6kb upstream of exon 2. There are four transcriptional
start sites distributed over 28bp of the promoter sequence
(Figure 3B). Examination of the 50 genomic ﬂanking
region did not reveal canonical TATA or CAAT motifs.
30RACE (Figure 3C) showed a single consensus
AUUAAA polyadenylation signal at position 3232 in
the transcript, with respect to the most 50 transcription
start site. The full transcript is 3259nt in length, in
agreement with the northern blot data, after allowing for
addition of the poly(A) tract. Comparison of the full
cDNA sequence with the genomic DNA sequence showed
that zebraﬁsh eno2 is composed of 12 exons distributed
over 18.6kb of genomic sequence (Figure 3D). The
boundary between intron 1 and exon 2 is a single
nucleotide 50 of the ATG translational initiation codon,
such that the obligatory A residue at position –3 of the
Kozak consensus sequence is located within the 30 end of
exon 1 (Figure 3B). The genomic organization of zebraﬁsh
eno2 is very similar to human ENO2, which also contains
12 exons, the ﬁrst of which is untranslated (35). The length
of each protein-encoding exon is identical between human
and zebraﬁsh, as are the phases of the splice boundaries
with respect to protein translation (Supplementary Data,
Table 1). Exon 12 of the zebraﬁsh gene encodes the
C-terminus of the protein and a 30UTR of 1882bp.
Expression ofan eno2 promoter construct in vivo
We identiﬁed a genomic BAC clone, zC51M24, from
the CHORI21 library, which contained the 50 end of the
zebraﬁsh eno2 gene and genomic ﬂanking region.
We generated reporter constructs in which expression
of enhanced green ﬂuorescent protein (GFP) was under
transcriptional control of fragments of the 50 genomic
region of zebraﬁsh eno2. Constructs in which expression of
Figure 2. The expression pattern of zebraﬁsh eno2. A digoxigenin labelled cRNA probe complementary to the 50 segment of the eno2 open reading
frame and 50UTR was used to examine the expression pattern of eno2 in adult, embryonic and larval zebraﬁsh by northern blot hybridization
and RNA in situ hybridization. (A) Northern blot adult tissues. Total RNA (1.5mg/lane) derived from adult brain (B), gut and liver (G) and muscle
(M) was separated by denaturing gel electrophoresis and the 18S rRNA band photographed (middle panel) to conﬁrm equal sample loading before
northern transfer. The blot was probed sequentially with the eno2 cRNA probe (upper panel) and a probe to b-actin (lower panel). Bound probe
was detected using a light-emitting substrate and exposure to photographic ﬁlm. (B and C) RNA in situ hybridization, adult brain. Parasagittal
sections of adult zebraﬁsh brains (rostral left, dorsal up) were hybridized with the eno2 antisense cRNA probe (B, upper panel and inset), a control
sense eno2 cRNA probe (B, lower panel) or a cRNA probe to an oligodendrocyte marker, mpz (C). Hybridized probe was detected using a
colorigenic substrate producing a purple reaction product. The morphology of eno2-expressing cells was examined at high power (B, inset panel). The
topographical locations of cells expressing eno2 were identiﬁed as illustrated in the accompanying schematic (middle panel). Key: Dl, dorsal
telencephalon, lateral zone; Dp, dorsal telencephalon, posterior zone; PGZ, periventricular grey zone of optic tectum; TeV, tectal ventricle; TeO,
optic tectum; TS, semicircular torus; Val, valvula cerebelli; G, granule cell layer of cerebellum; P, Purkinje cell layer of cerebellum; CCe, corpus
cerebellaris; Lca, caudal lobe of cerebellum; LX, vagal lobe; SRF, IMRF, IRF, superior, intermediate and inferior reticular formation; MLF,
medial longitudinal fascicle; LR, lateral recess of diencephalic ventricle; Hd, dorsal zone of periventricular hypothalamus; DIL, diﬀuse nucleus
of the inferior lobe; ON, optic nerve (11). (D) Northern blot, embryo and larval samples. Total RNA (1.5mg/lane) from whole embryo/larvae
lysates at 24–216hpf was separated by denaturing gel electrophoresis and the 18S rRNA band photographed (lower panel) to conﬁrm equal
sample loading before northern transfer. The blot was probed with the eno2 antisense cRNA probe under identical conditions to (A). (E) Whole
mount in situ hybridization. AB
  zebraﬁsh larvae were ﬁxed and hybridized with the eno2 antisense cRNA probe (right) or a sense control eno2
cRNA probe (left). Hybridized probe was detected using the purple colorigenic substrate shown in (B). Lateral views are shown of zebraﬁsh
larvae (rostral left, dorsal up) at 24, 48 and 72hpf. The arrowheads indicate weak hybridizing signal in the developing nervous system of the
24hpf embryo.
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zebraﬁsh eno2 genomic sequence 50 to exon 1 did not show
detectable GFP expression in microinjected embryos up to
4 days of age (data not shown). Analysis of the eno2
genomic sequence using cpgplot (http://www.ebi.ac.uk/
emboss/cpgplot/), identiﬁed a putative CpG island in the
ﬁrst intron of the eno2 gene, from positions +788 to
+988, measured from the 30 boundary of exon 1
(Supplementary Data, Figure 2). Since CpG islands
often overlap important regulatory elements, we incorpo-
rated intron 1 into a larger reporter construct (Figure 3C).
A 12kb fragment of the eno2 gene was captured from the
BAC by gap repair recombination, into an acceptor
plasmid that contained a GFP-poly(A) cassette fused to
the 30 eno2 homologous arm. The resulting reporter
construct contained 12kb of the eno2 gene spanning
from 8kb upstream of exon 1, through intron 1, to exon 2,
with eGFP-PolyA inserted in frame into exon 2. The entire
cassette was ﬂanked by I-Sce1 meganuclease sites. The
plasmid was microinjected into single cell zebraﬁsh
embryos, together with I-Sce1 enzyme and buﬀer (3,36).
Starting at around 48hpf GFP expression was seen in
the nervous systems of  30% of microinjected embryos.
A mosaic pattern of expression was evident, allowing
microscopic inspection of individual cells. GFP-expressing
cells showed neuronal morphology, with individual GFP-
expressing cell bodies visible throughout all parts of the
central nervous system (Figure 4A). GFP-expressing
axons were visible in both the central and peripheral
nervous systems. We raised all surviving microinjected ﬁsh
to sexual maturity; pre-selection for GFP-expressing
embryos was not carried out, in order to allow
ascertainment of the crude germline transgenesis rate for
the technique. We analysed genomic DNA extracted from
pooled embryos resulting from outcross of each micro-
injected ﬁsh with a wild-type control (Figure 4B). A total
of 132 adult F0 zebraﬁsh ﬁsh were assayed for germline
transmission in this manner. Five ﬁsh were identiﬁed
that transmitted the transgene through the germline,
suggesting a crude germline transgenesis rate of  4%.
We established transgenic lines from each of these
germline mosaic F0 ﬁsh. The transgene alleles for each
of these lines have been designated Pt401–405 inclusive.
In order to ascertain the relative transgene expression
level of each line, we subjected the brains of adult
transgenic ﬁsh to northern blot analysis. The eno2 probe
shown in Figure 2A hybridized with both the endogenous
eno2 mRNA and the chimeric eno2-GFP transcript. The
endogenous mRNA acted as a loading control, facilitating
comparison of the transgene expression level between
diﬀerent transgenic lines (Figure 4C). Lines Pt401–404
showed a single transgene transcript of expected size,
1.2kb. Line Pt404 showed the highest expression level in
adult brain, Pt402 showed the lowest level; Pt401 and
Pt403 showed an intermediate level of expression. Line
Pt405 showed an intermediate expression level of the eno2-
GFP transcript and an additional unexpected 1.6kb GFP-
hybridizing transcript of lower abundance.
The F2 and F3 generations of all ﬁve transgenic
Tg(eno2:GFP) lines showed expression of GFP in the
nervous system, in an identical pattern (Figure 4D–F).
Weak GFP expression was ﬁrst detected in the spinal cord
and brain at 24–30hpf and increased thereafter, such that
GFP was readily visible by epiﬂuorescence microscopy
Figure 3. The zebraﬁsh eno2 gene and promoter. (A)5 0RACE was used to map the eno2 transcription start site. An ethidium bromide stained 1.8%
agarose gel is shown. Lane 1: size marker—annotations show size in base pairs. Lanes 2 and 3: ﬁrst strand cDNA was derived from reverse
transcription of RNA that was either treated with TAP (lane 2, TAP
+) or untreated (lane 3, TAP
–), prior to RACE adapter ligation. The cDNA was
then ampliﬁed by PCR using a RACE adapter 50 primer and a gene-speciﬁc eno2 30 primer. Lanes 4 and 5: TAP
+ (lane 4) and TAP
– (lane 5) ﬁrst
strand cDNA samples, identical to those used as templates for the reactions shown in lanes 2 and 3, were ampliﬁed by PCR using two eno2 gene-
speciﬁc primers. (B) The genomic sequence encompassing the eno2 promoter. The four transcriptional start sites delineated by 50RACE are labelled
with arrows (+1, +12, +22, +28). Numbering is shown with respect to the most 50 start site. Exon sequence is shown in upper case; 50 ﬂanking
sequence and intron sequence is shown in lower case. The boundary between exons 1 and 2 at position+73 is shown; the splice donor consensus is
underlined. The ATG translational initiation codon in exon 2 is underlined, and the obligate A residue of the Kozak consensus at position  3 with
respect to the ATG codon is highlighted in black. (C) The schematic illustrates the genomic organization of eno2 and the DNA constructs used to
generate the transgenic zebraﬁsh shown in Figures 4–8.
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nervous system was brightly ﬂuorescent (Figure 4C
and D), the ﬂuorescent signal ﬁlling the outline of the
brain and spine. Using confocal microscopy, individual
GFP-expressing neurons and their axons were visible in
the brain, spine and periphery. GFP-expressing axons
were visible within segmental spinal nerve roots, exiting
the spinal cord and passing either ventrally and caudally,
or dorsally and caudally to innervate somatic muscles and
tegument (Figure 4E, arrows). Individual neurons within
the grey matter of the developing spinal cord expressed
GFP in their cell bodies, and GFP-positive axons were
visible running parallel to the long axis of the cord in the
ventral funiculus (Figure 4F). Some GFP-expressing
neurons within the central spinal grey matter gave rise
to axons that entered the ventral funiculus (Figure 4F,
arrow). GFP expression was also visible in other neural
structures in Tg(eno2:GFP) larvae from each line, includ-
ing the retina, the lateral line nerves and ganglia and
peripheral nerves in the facial region (data not shown).
Sections from adult Tg(eno2:GFP) brains derived from
each of the transgenic lines were examined for GFP
expression by indirect IHC (Figure 5A). GFP expression
was seen throughout the brain, and was most prominent
in the olfactory bulb, telencephalon, optic tectum,
Purkinje cell and molecular layers of the cerebellum and
the brainstem reticular formation; GFP-expressing cells
showed neuronal morphology, with large cell bodies and
axons (Figure 5B). We employed double indirect immuno-
ﬂuorescence and confocal microscopy in order to establish
the nature of the cells expressing the eno2:GFP transgene
(Figure 5C–F). GFP-expressing cells also expressed a
variety of neuronal and neurochemical markers. ChAT-
expressing cholinergic neurons in all parts of the brain
expressed GFP, the highest levels being evident in large
cholinergic neurons of the brainstem. Some groups of
inhibitory GABAergic neurons also showed GFP expres-
sion (Figure 5F), although many of the clusters of small
GABAergic neruons identiﬁed in the diencephalon did not
show GFP expression. Catecholaminergic neurons were
identiﬁed by their expression of tyrosine hydroxylase
(TH). The most robust GFP expression in catecholami-
nergic neurons was seen in dopaminergic cells of the
olfactory bulbs (Figure 5D); dopaminergic neurons in the
pretectal area also exhibited prominent GFP immunor-
eactivity. Other TH-positive groups showed variable
expression of GFP; for example the large dopaminergic
neurons of the periventricular hypothalamus did not
express detectable GFP (data not shown). Cerebellar
Purkinje cells were identiﬁed topologically, morphologi-
cally and by immunoreactivity for IP3R1; these cells
expressed GFP robustly (Figure 5E). In contrast to the
widespread expression of eno2 in diﬀerent populations of
neuronal cells, co-localization of GFP with the glial
marker GFAP was not observed (data not shown).
A similar pattern of co-localization between GFP
and neuronal markers was evident in samples derived
from 4-day old transgenic larvae (Supplementary Data,
Figure 3). However, at this earlier time point, there was
greater variability in GFP expression within groups of
morphologically and neurochemically deﬁned groups of
neurons.
We examined expression of the GFP transgene outside
the CNS, since expression in non-neural tissues might
complicate future phenotypic analysis of transgenic lines
made using this promoter. By epiﬂuorescence micro-
scopy, non-neural GFP expression in four of ﬁve lines
(alleles Pt401–404) was limited to the distal extremities of
Figure 4. Expression of a 12kb eno2 promoter construct in transgenic
zebraﬁsh. The 12kb eno2:GFP construct shown in Figure 3C was
microinjected into single-cell zebraﬁsh embryos and stable transgenic
lines were derived as described in the text. (A) Lateral view of the head
and rostral trunk region of a microinjected zebraﬁsh larva (rostral left,
superior up) at 72hpf by epiﬂuorescence microscopy, showing punctate
mosaic GFP expression. Key: Tel, telencephalon; TeO, optic tectum;
MdO, medulla oblongata; SC, spinal cord; R, retina; L, lateral line
ganglion. The yolk sac, Y, is autoﬂuorescent. (B) Transgenic founders
were identiﬁed by transmission of the GFP transgene to progeny
embryos by genomic PCR. The picture shows an ethidium bromide
stained agarose gel. Lanes 2 and 4, genomic DNA from embryos
derived from transgenic parents; lanes 1 and 3, genomic DNA from
embryos derived from non-transgenic parents; lane 5 (‘–c’), genomic
DNA from wild-type embryos; lane 6 (‘+c’), genomic DNA from wild-
type embryos spiked with GFP plasmid. (C) Northern blot analysis of
GFP expression in stable transgenic lines. Total RNA (1.5mg/lane)
derived from adult brains of each transgenic line was subjected to
denaturing gel electrophoresis and northern transfer and the resulting
blot hybridized with a probe to eno2 that is complementary to
sequences within both the endogenous eno2 transcript and the eno2-
GFP transgene mRNA. The asterisk indicates the unexpected addi-
tional hybridizing band detected in line Pt405 and discussed in the text.
(D) GFP expression in living stable Tg(eno2:GFP)
Pt401 zebraﬁsh larvae
by epiﬂuorescence microscopy. An oblique lateral view of an F3
generation Tg(eno2:GFP)
Pt401 larva is shown at 5 days post-fertiliza-
tion, compared with a wild-type AB
  larva (both larvae are orientated
rostral left, dorsal up). The yolk sac, Y, is autoﬂuorescent in both
larvae. The major GFP-expressing divisions of the nervous system are
labelled; the key is the same as (A). (E) Lateral confocal microscopic
image of the spinal cord and trunk of an F3 generation
Tg(eno2:GFP)
Pt404 larva at 5 days post-fertilization. GFP expression
is seen within the segmental spinal nerve roots (arrows) and in cell
bodies within the spinal cord (bracketed). (F) High-power view of
spinal cord, showing GFP expression in individual neurons in the
spinal grey matter and axons in the ventral funiculus. Occasional GFP-
expressing axons (arrow) were seen entering the ventral funiculus from
the grey matter.
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ﬁn expression was faint and transient. In the line with
highest CNS expression, Pt404, GFP ﬂuorescence in the
ﬁns became fainter with increasing age, but did not
disappear. In the remaining line (Pt405), more extensive
ectopic expression of GFP was evident in myoseptae,
cartilage of the cranium and developing ﬁn rays.
We subjected larvae from each transgenic line to RNA
in situ hybridization using a probe for the GFP mRNA,
providing a more sensitive method for demonstrating
non-neural expression (Figure 6). Larvae from lines
Pt401–403 showed an identical expression pattern;
examples from line Pt401 are shown in Figure 6A.
Robust expression of GFP mRNA was seen in the
nervous system and, between 30 and 48hpf, in the
developing ﬁns. By 72hpf GFP mRNA was no longer
detected in the ﬁns (except along the distal margins of
the pectoral ﬁns), corresponding to the transient GFP
expression seen by epiﬂuorescence microscopy.
Expression outside the nervous system was not otherwise
seen in lines Pt401–403. In line Pt404, which showed the
highest expression level of GFP in adult brain, GFP
mRNA was also abundant in the larval brain and spinal
cord. In addition, GFP mRNA was detected in the
developing ﬁns at 48hpf and in the developing gut at
96hpf (Figure 6B). The weak signal in the gut was
only apparent after prolonged development of the
histochemical reaction. In line Pt405, widespread expres-
sion of GFP mRNA outside the nervous system was seen
in a similar distribution to that observed by epiﬂuores-
cence microscopy, in the ﬁns, myospetae and developing
head region. Next, we performed a northern blot analysis
of non-neural tissues derived from adult transgenic
ﬁsh from lines Pt404 and Pt401 (Figure 6D), speciﬁcally
asking whether the GFP transgene was expressed in the
adult gut in line Pt404. Robust GFP expression in the
brain was detected by this technique, but GFP mRNA
was not detected in gut, muscle or testis from either line,
even after 5-fold over-exposure of the blot. The b-actin
loading control conﬁrmed that equal amounts of mRNA
were loaded in each lane of the blot. The failure to
detect GFP mRNA in the gut of adult Tg(eno2:GFP)
Pt404
ﬁsh suggests that expression in the gut during develop-
ment is transient, or that adult gut expression occurs at a
very low level, beyond the limit of detection by this
technique. Finally, we examined intact adult ﬁsh by
epiﬂuorescence microscopy (Figure 6E). Lines Pt404 and
Pt405 showed persistent weak expression of GFP along
the extreme distal margins of the ﬁns. In addition,
ﬂuorescent sensory nerve axons in the peripheral nervous
Figure 5. GFP expression in the brains of adult Tg(eno2:GFP) zebraﬁsh. (A) Parasagittal sections of Tg(eno2:GFP)
Pt404 (upper panel) and wild-type
(lower panel) brain were labelled with an antibody to GFP. Bound antibody was detected using a histochemical reaction with a red product
and nuclei were labelled with a blue counterstain. GFP expression was apparent throughout the brain of transgenic adults. (B) High-power view of
medullary reticular formation of Tg(eno2:GFP)
Pt404 zebraﬁsh brain, showing GFP expression in cells with neuronal morphology. The arrows
show GFP-expressing neurons with axons in the plane of the section. (C–F) Double label confocal images of Tg(eno2:GFP)
Pt404 adult brains.
Each panel consists of a set of three images: (i) Upper image; red: a cell type-speciﬁc marker of interest was localized using speciﬁc antibodies. C:
Medulla; ChAT, choline acetyltransferase; cholinergic neurons; D: Olfactory bulb; TH, tyrosine hydroxylase; dopaminergic neurons; E: cerebellum;
IP3R1, IP3 receptor 1; cerebellar Purkinje cells; D: thalamus; GABA, g-amino butyric acid; inhibitory neurons; (ii) Middle image, green: GFP
expression was localized in the same sections using a GFP antibody; (iii) Lower image: the merged images show co-localization of GFP and the
cell type-speciﬁc marker (yellow), and were counterstained with DAPI to show nuclei (blue). The scale bar (10mm) for each set of images is shown in
the lower panel.
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Tg(eno2:GFP)
Pt404 zebraﬁsh.
These data show that the 12kb eno2 promoter fragment
drives transgene expression in neurons throughout the
CNS, including neuronal populations of speciﬁc interest
to neurodegenerative disorders, such as cerebellar
Purkinje cells, dopaminergic neurons and cholinergic
neurons. Expression starts at 24–30hpf, but does not
reach maximal levels until around 72hpf, after the major
divisions of the nervous system are formed and when
functioning neurons expressing markers of diﬀerentiation
are present. Expression outside the nervous system is
limited, occurring transiently in the ﬁns and at very low
levels in the gut. This promoter element may, therefore, be
useful in constructing transgenic zebraﬁsh models of
neurodegenerative disease.
Transgenic fish expressing 4-repeat Tau underthe
eno2promoter
In order to test whether the eno2 promoter could be used
to express genes associated with neurodegeneration, we
produced transgenic zebraﬁsh expressing the 4-repeat
isoform of human microtubule-associated protein Tau
(MAP-Tau4R) (37). MAP-Tau4R contains four carboxy-
terminal tandem repeat sequences of 31–32 amino acids
within the microtubule binding domain, and is deposited
in cerebral neurons in the human neurodegenerative
disorders progressive supranuclear palsy and corticobasal
degeneration (38). In contrast to the eno2:GFP construct
described above, which was generated by making
a translational fusion between exon 2 of the eno2 gene
and GFP, we were anxious to avoid altering the primary
sequence of MAP-Tau4R. Consequently, we used a
cDNA encoding MAP-Tau4R to replace the ORF of
eno2 in its entirety, relying on accurate and eﬃcient
splicing of the intron present in the chimeric
eno2:MAP-Tau4R transcript to generate an eno2:Tau
transcriptional fusion with a Kozak consensus sequence
at the translational initiation codon (Figure 3B).
In addition, we added an internal ribosome entry site
and GFP sequence to the cassette, in order to allow visual
genotyping of transgenic ﬁsh by ﬂuorescence microscopy.
We found that the IRES sequence functions too weakly
in ﬁsh to be reliably used for this purpose (data not
shown), and so we identiﬁed zebraﬁsh carrying the
transgene by PCR genotyping using the GFP primers
shown in Figure 4B. Transgenic Tg(eno2:Tau) lines
were generated as described above. Heterozygous
Tg(eno2:Tau) zebraﬁsh larvae comprised a Mendelian
fraction of each clutch of eggs and were viable and fertile
as adults. The adults are currently 12 months old and
show no evidence of increased mortality or reduced
fertility in comparison with wild-type zebraﬁsh. A full
histological, biochemical and behavioural characterization
of Tg(eno2:Tau) zebraﬁsh will be reported separately.
In the present study, we concentrated on assessing
the utility of the zebraﬁsh eno2 promoter for construction
of this type of model, and here we report relevant ﬁndings
in one line of transgenic zebraﬁsh, designated
Tg(eno2:Tau)
Pt406.
Figure 6. GFP expression outside the central nervous system of Tg(eno2:GFP) zebraﬁsh. (A) Tg(eno2:GFP)
Pt401 larvae at 28 and 72hpf were
subjected to RNA in situ hybridization using a cRNA probe complementary to GFP. The arrowheads indicate GFP mRNA expression in the
developing ﬁns in the 28hpf embryo, and in the distal margins of the pectoral ﬁns in the 96hpf larva. (B) High-power view of the trunk region of a
Tg(eno2:GFP)
Pt404 larva at 96hpf. Key: SC, spinal cord; G, gut. The arrowheads indicate weak expression of the transgene in the developing
intestine. (C) High-power view of the trunk region of a Tg(eno2:GFP)
Pt405 larva at 96hpf. Key: SC, spinal cord; F, ﬁns. The arrowheads indicate
ectopic expression of the transgene in myoseptae. (D) Northern blot analysis of tissues derived from adult Tg(eno2:GFP)
Pt404 and Tg(eno2:GFP)
Pt401
zebraﬁsh. Key: B, brain; M, muscle; G, gut; T, testis. Two micrograms total RNA from each tissue was subjected to denaturing electrophoresis and
northern transfer. The blot was probed using a cRNA probe to GFP and exposed for 60s (upper panel) or 5min (middle panel). The blot was then
re-probed with a cRNA probe to b-actin (lower panel). (E) Epiﬂuorescence microscopy of an adult Tg(eno2:GFP)
Pt404 zebraﬁsh. High-power views
are shown of the caudal peduncle region (upper panel) and distal anal ﬁn (lower panel). Arrowheads indicate GFP expression in sensory nerves
(upper panel) and distal ﬁn margins (lower panel).
6510 Nucleic Acids Research, 2007, Vol. 35, No. 19First, we asked whether splicing of eno2 intron 1 from
the chimeric eno2:Tau transcript occurred with suﬃcient
eﬃciency and ﬁdelity to allow expression of the transgene.
This is an important consideration, since the transgene
sequence was inserted 2nt downstream of the eno2 exon 2
splice acceptor, potentially modifying the splicing event.
Northern blots were constructed using total RNA from
wild-type and Tg(eno2:Tau)
Pt406 zebraﬁsh brains
(Figure 7A). An antisense cRNA probe to GFP hybri-
dized with a single 2.5kb band, which is the expected size
of the transgene mRNA after splicing. A duplicate blot
was hybridized with a cRNA probe to eno2 exons 1–3.
As expected, this detected the endogenous 3.5kb eno2
transcript in both wild-type and transgenic samples, but
also hybridized with a 2.5kb RNA from transgenic brain,
suggesting that the 2.5kb species is formed by splicing of
intron 1 from the chimeric transcript. The primary
transcript derived from the transgene is predicted to be
6.5kb in size, and a band of this size was not seen even
after prolonged exposure of either blot, indicating that
splicing occurred eﬃciently. It should be noted that the
native eno2 transcript presents 307nt of sequence com-
plementary to the probe, but the chimeric eno2-Tau
transcript presents only 72nt of sequence complementary
to the probe. Therefore, the relative abundance of the two
transcripts cannot be estimated from the relative signal
intensities of the hybridizing bands. In order to examine
the ﬁdelity of splicing, we performed RT–PCR, using a 50
primer complementary to eno2 exon 1 and a 30 primer
complementary to the human MAP-Tau4R cDNA
(Figure 7B). A single 400bp product, the expected size
of the PCR product after intron 1 splicing, was ampliﬁed
from cDNA derived from Tg(eno2:Tau)
Pt406 zebraﬁsh
brain, but not wild-type brain. No other bands were
generated, suggesting that splicing occurred accurately at
the native boundaries. We cloned the RT–PCR product
and sequenced 10 randomly chosen clones (Figure 7C).
All 10 clones showed identical sequence spanning the
junction between eno2 exon1 and human 4R-Tau.
The junction occurred at an identical location to the
exon1–exon2 junction in the native eno2 mRNA, and
accurately re-constituted the Kozak consensus signal
for translation of the 4R-Tau transgene. These data
conﬁrm that the native eno2 intron 1 splice signals were
operational even after the replacement of exon 2 with
a heterologous transgene sequence.
We next asked whether the resulting eno2-Tau tran-
script was translated to produce detectable protein.
Western blot analysis was undertaken using lysates from
Tg(eno2:Tau)
Pt406 zebraﬁsh brains, wild-type zebraﬁsh
brains and human post-mortem cerebral cortex
(Figure 8A). Equal amounts of protein were loaded in
each lane and the blot was sequentially probed using: (i) a
monoclonal antibody that recognizes all splice isoforms of
human MAP-Tau, but which does not react with zebraﬁsh
microtubule-associated proteins, followed by: (ii) an actin
antibody that recognizes both the human and zebraﬁsh
proteins. Bands representing the six reported human
MAP-Tau isoforms were evident in the human cortex
sample (37). A single abundant band corresponding to the
MAP-Tau4R transgene was observed in the sample
derived from Tg(eno2:Tau)
Pt406 zebraﬁsh brain; this was
not seen in the sample derived from control zebraﬁsh
brain. Densitometric measurement suggested that the
transgenic ﬁsh brain expressed 8–10-fold higher levels of
MAP-Tau relative to the b-actin control than human
cortex. These data suggest that the eno2 promoter drives
high-level transgene expression in adult zebraﬁsh brain.
To ascertain the expression pattern of transgenic 4R-Tau,
we undertook a preliminary histological examination of
adult Tg(eno2:Tau)
Pt406 zebraﬁsh brains (Figure 8B). IHC,
using the primary antibody used in Figure 8A, showed
widespread expression of human MAP-Tau4R through-
out Tg(eno2:Tau)
Pt406, but not wild-type, zebraﬁsh brain.
The transgene product was readily detectable owing to its
abundant expression. For example, in the optic tectum,
large aﬀerent axons parallel to the pial surface of the brain
Figure 7. Splicing of intron 1 from a chimeric eno2:Tau transcript
in vivo. Stable transgenic zebraﬁsh were generated using the eno2:Tau
transgene shown in Figure 3C. (A) Two micrograms of total RNA
derived from Tg(eno2:Tau)
Pt406 (‘Tau’) or wild-type (‘AB
 ’) adult
zebraﬁsh brains was separated by denaturing gel electrophoresis and
the 18S rRNA band photographed (lower panel) to conﬁrm equal
sample loading before northern transfer. Duplicate blots were probed
using digoxigenin-labelled cRNA probes complementary to GFP (left
blot) or eno2 (right blot), as shown in Figure 2A. The endogenous eno2
and chimeric eno2:Tau transcripts are labelled. (B) An ethidium stained
1.8% agarose gel is shown; lane 1 contains DNA marker, annotations
show size in base pair. Total RNA, derived from Tg(eno2:Tau)
Pt406
(lane 2, ‘Tau’) or wild-type (lane 3, ‘AB
 ’) adult zebraﬁsh brains, was
subjected to reverse transcription followed by PCR ampliﬁcation using
a5 0 primer speciﬁc for eno2 exon 1 and a 30 primer speciﬁc for human
4R-Tau (upper panel). Aliquots of the same cDNA samples were then
subjected to PCR ampliﬁcation using two b-actin primers (lower panel).
(C) The eno2-Tau PCR product from (B) was cloned and sequenced.
The schematic shows the exon 1 splice donor and exon 2 splice acceptor
sequences from the endogenous eno2 gene, the chimeric eno2:Tau splice
acceptor, and the sequence of the eno2-Tau RT-PCR product across
the boundary between the eno2 and human Tau sequences.
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to the pial surface in the deep laminae were densely
labelled with the Tau antibody (Figure 8B, lower left
panel). In addition, the neuropil was heavily labelled, as
were neurons in multiple laminae. High-power examina-
tion revealed abnormal cytoplasmic expression of Tau in
many neurons (Figure 8B, lower right panel). Neuronal
somatic Tau immunolabelling was dense and showed a
refractile pattern suggestive of ﬁbrillar deposition in
several areas, including the thalamus. These ﬁndings
resembled neuroﬁbrillary tangles and neuropil threads
seen in human tauopathies.
These data show that the 12kb eno2 promoter element
drives expression of a heterologous transgene in neurons
of the zebraﬁsh brain at suﬃciently high levels to allow
detection of the transgene product pathologically and
biochemically, and the generation of histological changes
reminiscent of human disease.
DISCUSSION
Mammalian and fish enolase genes
Zebraﬁsh eno2 and mammalian ENO2 share extensive
homology, including regulatory sequences, genomic orga-
nization and predicted amino acid sequences. The genes
are likely derived from a common ancestor, and the
demonstration of other zebraﬁsh enolase genes predicting
proteins with homology to mammalian a- and b-enolase
isoenzymes suggests that the gene duplications that
presumably led to distinct functionally specialised enolase
isoenzymes occurred before ﬁsh and mammals diverged in
evolution. The conserved neuronal expression pattern of
eno2 suggests that g-enolase might have speciﬁc functions
in neurons. Two putative eno1 orthologues were found in
zebraﬁsh. An ENO1 processed pseudogene is present
within the human genome (39), but it shows characteristics
of sequence inserted by reverse transcription, in particular
lacking introns. This was not the case in the zebraﬁsh
genes, and it seems likely that the zebraﬁsh has two copies
of the eno1 gene.
Expression of an ENO2 orthologue in zebraﬁsh has
been previously described in a high-throughput in situ
hybridization analysis (accessible on line: Thisse and
Thisse 2004, http://zﬁn.org/cgi-bin/webdriver?MIval=
aa-markerview.apg&OID=ZDB-GENE-040704-27). The
expression pattern described in the present study is similar
to the previous work, except that an earlier time of onset
of expression in trigeminal ganglia, and expression in
developing myotomes, was described in the earlier study.
A likely explanation for these minor diﬀerences relates to
the probe sequences used in the studies. We selected a
short (307nt) probe complementary to the 50 end of the
eno2 transcript because it showed no cross-hybridization
with other enolase transcripts, whereas probes comple-
mentary to the 30 end of the eno2 open reading frame
Figure 8. Expression of 4R-Tau in the brains of adult Tg(eno2:Tau) zebraﬁsh. (A) Ten micrograms of protein derived from wild-type AB
  zebraﬁsh
brain, normal human post-mortem cerebral cortex or Tg(eno2:Tau)
Pt406 zebraﬁsh brain was separated by SDS–PAGE and transferred to a PVDF
membrane. The resulting western blot was probed sequentially with an antibody speciﬁc to human Tau (upper panel) and an antibody that binds to
both human and zebraﬁsh actin (lower panel). (B) Sections from wild-type AB
  (upper two panels) or Tg(eno2:Tau)
Pt406 (lower two panels) zebraﬁsh
brains were immunolabelled using the human Tau-speciﬁc antibody shown in (A). Bound antibody was detected using a peroxidase-conjugated
secondary antibody and a histochemical reaction with a red reaction product, as shown in Figure 5A. Nuclei were counterstained blue. The left two
panels show low-power views of the optic tectum to demonstrate the regional pattern of Tau expression in axons and neuropil. The right two panels
show high-power views of the thalamus to demonstrate expression of Tau in the cell bodies and proximal processes of neurons, which are identiﬁed
by their large pale-staining nuclei.
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used in the high-throughput study was generated from a
plasmid containing 1379bp of the eno2 open reading
frame. Although the greater length of this probe likely
enhanced its sensitivity for detecting low-level expression
at earlier time points, our data suggest that this may have
been at the expense of speciﬁcity.
The eno2 regulatory region
Similar to the human and rat genes, the zebraﬁsh eno2
promoter lacks canonical TATA, CAAT or initiator
sequences, shows multiple transcriptional start sites, and
the gene contains an untranslated ﬁrst exon that is spliced
to a second exon containing the ATG translational
initiation codon (35,40). Approximately 40% human
genes have untranslated ﬁrst exons (41), and there are
several examples of genes in which important regulatory
elements lie in the ﬁrst intron following an untranslated
ﬁrst exon (42). In the zebraﬁsh gene, we found a putative
200bp CpG island in the ﬁrst intron; analysis of the rat
and human ﬁrst introns similarly showed short CpG
islands. Although the introns from the three diﬀerent
species showed very limited sequence conservation
overall, the CpG islands were more highly conserved
(human-rat 64%, human-zebraﬁsh 46%; Supplementary
Data, Figure 2). A previously reported in vitro analysis of
the rat NSE promoter suggested that there may be a
neuron-speciﬁc enhancer sequence within the ﬁrst intron
of the rat gene (43). Our data in transgenic ﬁsh in vivo are
compatible with the similar presence of neuronal regula-
tory elements in the ﬁrst intron of the zebraﬁsh eno2 gene,
suggesting phylogenetic conservation of an intronic
neuronal enhancer. The important elements could be
delineated by deletion analysis, to establish whether the
phylogenetically conserved sequences are necessary or
suﬃcient for promoter activity and speciﬁcity.
Previous attempts to construct transgenic murine
models of Alzheimer’s disease used a 1.8kb fragment of
the rat NSE promoter to drive expression of the amyloid
precursor protein b-APP. The transgene was expressed
at insuﬃcient levels to reproduce the full pathological
proﬁle of Alzheimer’s disease in transgenic animals
(44,45). The 1.8kb rat NSE construct likely contains a
small subset of the cis-acting signals that contribute to
physiological expression levels of the native transcript,
and lacks the regulatory elements present in the ﬁrst intron
of the rat gene. This might account for its failure to drive
expression at suﬃcient levels to provoke pathology. The
12kb zebraﬁsh eno2 promoter fragment expressed the
human MAP-Tau gene in hemizygous transgenic animals
at 8-fold higher levels than in human brain. The 12kb
fragment contains the putative neuronal intronic enhan-
cer; in addition a generic intron enhances transgene
expression levels in transgenic animals (46,47), possibly
through mechanisms other than the presence of transcrip-
tional regulatory regions within the intron, such as linked
intron splicing and nuclear mRNA export (48,49).
Despite the 12kb eno2 promoter construct expressing
transgenes at high levels, it does not contain all of the
cis-acting signals present in the zebraﬁsh gene, since
the reporter transgene does not fully recapitulate the
expression pattern of the endogenous transcript. Thus, in
adult Tg(eno2:GFP) brain from each of the lines, little
GFP expression was visible in the cerebellar granule cell
layer, even though the endogenous transcript was
abundantly expressed in this brain region. Large frag-
ments of the regulatory region of the murine ENO2 gene
are required to recapitulate the physiological gene
expression pattern in mice; a 250kb BAC reporter
containing the entire murine ENO2 locus, showed
expression of the transgene in a similar pattern to the
endogenous gene (50). Two further transgenic lines in
which transgene expression was driven by a 25kb genomic
fragment only partially recapitulated the expression
pattern of the endogenous transcript. Interestingly, one
of the principal diﬀerences between the 25kb and 250kb
regulatory elements was loss of transgene expression in
the granule cells of the cerebellum with the smaller
construct. This is similar to the pattern we observed in
Tg(eno2:GFP) zebraﬁsh, in which GFP expression was
absent from the cerebellar granule cell layer, despite
expression of the endogenous gene in this region. This
suggests that sequences responsible for g-enolase expres-
sion in cerebellar granule cells lie remote from the
immediate 50 region of the gene in both mouse and
zebraﬁsh. We saw ectopic GFP expression in
Tg(eno2:GFP) embryos in the distal margins of the ﬁns
in non-neural structures. This expression was presumably
due to the absence of an important non-neural repressor
element in the 12kb eno2 transgene construct, since we
observed the ﬁnding in multiple independent transgenic
lines. In addition, weak ectopic GFP expression was
observed in the gut of Tg(eno2:GFP)
Pt404 larvae. It is
unclear whether this is attributable to absence of an
important promoter element or to an artefact arising from
the site of genomic integration, since we did not observe
expression in the gut of other transgenic lines. However,
Pt404 shows the highest expression level and so might be
the only line in which low-level ‘leaky’ promoter activity
was detectable in the intestine. Ectopic expression in
myoseptae and cartilage of Tg(eno2:GFP)
Pt405 larvae was
presumably a result of a genomic integration site artefact,
since transgene expression was not seen in these locations
in other lines. Interestingly, an unexpected eno2 hybridiz-
ing band was seen on northern blot analysis of brain RNA
derived from this line, in addition to the expected
endogenous gene and transgene bands. This ﬁnding
suggests an aberrant splicing event between the transgene
and a gene in the vicinity of its genomic integration site,
perhaps accounting for the ectopic GFP expression
observed in this line.
Meganuclease-mediated transgenesis
The 12kb eno2 promoter fragment is suﬃciently small
that insertion of transgene sequences into the plasmid
construct is straightforward; the resulting plasmid
can be grown at high copy number in Escherichia coli
and DNA preparations made with ease. In addition,
the relatively compact nature of the construct allows for
eﬃcient transgenesis using the I-Sce1 technique. Had we
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esis rate amongst microinjection survivors would have
been much higher than the 4% we observed; assuming the
4% was a subset of the  30% that expressed GFP, we
might have expected to isolate 10–15% germline trans-
genics from the GFP-expressing embryos.
Tg(eno2:GFP) zebrafish
The stable lines of Tg(eno2:GFP) zebraﬁsh generated in
the course of this work may be useful for applications
demanding in vivo visualization of neurons and their
axons. NSE expression is generally considered a feature of
cells with neuronal diﬀerentiation (24). GFP-expressing
cells in Tg(eno2:GFP) embryos and larvae showed
morphological features of mature neurons, and were
visible throughout the neuraxis. Later stages of CNS
development or the eﬀects of neurotoxins or genetic
mutations that cause neurodegeneration could be directly
observed in these transgenic zebraﬁsh in vivo by epiﬂuor-
escence microscopy. In addition, peripheral nerve GFP
expression was visible through the dermis in adult
zebraﬁsh. There are few animal models in which
peripheral nerve axons can be directly observed, yet
there are a multitude of toxic and metabolic diseases to
which these axons are particularly susceptible. Potentially,
Tg(eno2:GFP) zebraﬁsh might provide a means to directly
observe disease progression in models of these pathologi-
cal processes.
Use ofthe zebrafish eno2 promoter toconstruct
transgenic diseasemodels
Our aim was to isolate a cis-acting promoter construct
that drives an appropriate spatial and temporal transgene
expression pattern at a suﬃcient level to allow its use in
the generation of transgenic disease models. The data
suggest that the eno2 promoter fulﬁls many of the requisite
properties for this application:
Spatial expression pattern. We observed expression of the
transgene in neurons of the brain, spine, retina and
peripheral nervous system in ﬁve independent transgenic
(eno2:GFP) lines. GFP expression was evident in neuronal
populations of speciﬁc relevance to the study of neurode-
generation, for example cerebellar Purkinje cells, motor
neurons and dopaminergic neurons. This spatial pattern is
appropriate for studying the diﬀerential susceptibility of
subgroups of neurons to proteins expressed ubiquitously
in neurons. One possible concern for the use of the eno2
promoter in transgenic disease models relates to ectopic
expression of the transgene in non-neuronal cells at the
distal margins of the ﬁns and also at low levels in
the developing gut. The ﬁns are robustly regenerative in
the zebraﬁsh; we routinely use tail ﬁn biopsy as a means to
obtain genomic DNA to determine the genotype of
transgenic zebraﬁsh, and the ﬁns regenerate rapidly
afterwards. It is very unlikely that an adverse phenotype
relating to the expression of transgene in the distal ﬁn
margins will impinge on the successful generation of ﬁsh
with neurodegenerative disease biochemistry. It is also
doubtful that the ectopic expression of transgenes in the
intestine, at the low level we observed relative to robust
CNS expression, will be deleterious to the future genera-
tion of disease models. Other promoters successfully used
for generating rodent models of neurodegenerative disease
show ectopic expression outside the CNS, for example
weak expression of the PrP promoter in the kidney and
heart (51). Furthermore, many human neurodegenerative
disease genes are expressed ubiquitously, but seem to exert
toxic eﬀects selectively in neurons.
Temporal expression pattern. Expression of the 12kb eno2
promoter starts at 24–28hpf, but increases signiﬁcantly
between 48 and 72hpf and persists through adulthood.
The relatively late onset of high-level expression may
avoid potentially deleterious eﬀects of early transgene
expression on the initial diﬀerentiation of neurons, but
will encompass the later stages of larval development
when screening approaches can still be deployed practic-
ably. Persistence of expression into adulthood will allow
examination of age-related progression of pathology in
transgenic ﬁsh.
Expression levels. We were concerned that transgene
expression from the 12kb eno2 promoter relies on
accurate and eﬃcient splicing of the eno2 ﬁrst intron
from a chimeric transcript in which the second exon is
replaced by a cDNA sequence of interest and the
remainder of the eno2 transcript is missing. However,
our studies show that splicing of intron 1 from the
chimeric transcript occurs with high eﬃciency and ﬁdelity,
accurately aligning the 30 end of exon 1 with the ATG
signal in exon 2, resulting in a Kozak consensus sequence.
This allowed eﬃcient translation of the transgene, with
steady-state levels of the Tau transgene being several fold
higher than the native protein in human brain tissue.
We have now used this promoter to express a variety of
transgenes and have observed similar ﬁndings in multiple
transgenic lines. The presence of the intron in the
promoter construct signiﬁcantly contributes to robust
transgene expression.
In summary, we have cloned and characterized a
zebraﬁsh eno2 promoter fragment, demonstrated its utility
in driving transgene expression in a neuronal pattern in
stable transgenic animals, and used it to generate a
zebraﬁsh Tauopathy model. Our current studies are
focussed on establishing whether Tg(eno2:Tau) zebraﬁsh
develop a full spectrum of phenotypic changes reminiscent
of human Tauopathies.
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